Genetic Editing for Healthcare

Bhupinder Singh, PhD, is working as a Professor at the Sharda School of Law at Sharda University Greater Noida, India. He is also a Honorary Professor at the University of South Wales, UK, and Santo Tomas University Tunja, Colombia. He has written three books, nearly 100 paper publications, and 163 presentations at international/national conferences and seminars, and has participated in more than 40 workshops, faculty development programs, and quality Improvement programs. He has taken over 25 courses at international universities, organized more than 59 events with international and national academicians and industry professionals, developed new courses, and served as editor-in-chief and co-editor for several journals. He has given talks at international universities and has been a resource person at international conferences around the world. His leadership, teaching, research, and industry experience spans more than 16 years. His research interests are health law, criminal law, research methodology, and emerging multidisciplinary areas as blockchain technology, IoT, machine learning, artificial intelligence, genome-editing, photovoltaic PV glass, Sustainable Development Goals, etc.Rishabha Malviya, PhD, is working as an Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. He has 12 years of research experience. His area of interest includes formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 200 research and review papers for national and international journals of repute. He has to his credit 58 patents (19 grants, 38 published, one filed) as well as many publications in reputed national and international journals. He has received an Outstanding Reviewer Award from Elsevier. He has authored and edited nearly 50 books (Wiley, CRC Press/Taylor and Francis, Springer, River Publisher, IOP Publishing, and OMICS Publishing Group) and authored over 30 book chapters. His name has included in the World’s Top 2% Scientists by Stanford University. He is a reviewer, editor, and editorial board member for more than 50 national and international journals of repute. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with B2B industry, Ingredient South Asia. He completed his BPharm from Uttar Pradesh Technical University and MPharm (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh, India. His PhD (Pharmacy) work was in novel formulation development techniques.Sahil Lal, PhD, is working as a Research Scholar at the Sharda School of Law at Sharda University, India. His areas of interests are contract law, international law, intellectual property rights, and criminal law. He has presented papers at international and national conferences and workshops.Sathvik Belagodu Sridhar, PhD, is currently working as an Associate Dean and Professor at the RAK College of Pharmacy (RAKCOP), RAK Medical and Health Sciences University, located in Ras Al Khaimah, United Arab Emirates. He received an FIP (International Pharmaceutical Federation) fellowship for higher training in renal clinical pharmacy at the Royal Adelaide Hospital and Queen Elizabeth Hospital in Adelaide, South Australia. Dr. Sridhar has been honored with a prestigious teacher award by the Society of Pharmaceutical Education & Research (SPER). He has also received training in pharmacovigilance at the Uppsala Monitoring Centre in Uppsala, Sweden. He has 25 years of experience in teaching and practicing clinical pharmacy in India, Malaysia, and the UAE. His research interests include medication safety, pharmacovigilance, pharmacoepidemiology, and renal and psychiatry clinical pharmacy. Dr. Sridhar has published more than 75 research papers in reputable national and international journals, along with book chapters. He has presented more than 75 research papers at national and international conferences and has been honored with many awards. He serves as a reviewer for various national and internal pharmacy practice-related journals. Dr. Sridhar completed his PhD in Clinical Pharmacy from Rajiv Gandhi University of Health Sciences, Bangalore, India.

• Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India Preface 1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology 2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing 3. Impact of Genomics on Drug Discovery and Clinical Medicine on Public Healthcare 4. Challenges and Approaches to Human Genome Editing 5. Precision Medicine Rhrough Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare 6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation 7. Biosafety Issues Relating to Genome Editing in Plants and the Impact on Human Health 8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology 9. Genomic Innovations in Drug Discovery and Clinical Medicine 10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India